LAVA Therapeutics N.V.

LAVA Therapeutics N.V.verified

LVTX

Price:

$1.74

Market Cap:

$45.77M

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody...[Read more]

Industry

Biotechnology

IPO Date

2021-03-26

Stock Exchange

NASDAQ

Ticker

LVTX

The PE Ratio as of December 2025 (TTM) for LAVA Therapeutics N.V. (LVTX) is -2.00

According to LAVA Therapeutics N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -2.00. This represents a change of 33.39% compared to the average of -1.50 of the last 4 quarters.

LAVA Therapeutics N.V. (LVTX) Historical PE Ratio (quarterly & annually)

How has LVTX PE Ratio performed in the past?

The mean historical PE Ratio of LAVA Therapeutics N.V. over the last ten years is -9.56. The current -2.00 PE Ratio has changed 1.99% with respect to the historical average. Over the past ten years (40 quarters), LVTX's PE Ratio was at its highest in in the September 2022 quarter at 31.55. The PE Ratio was at its lowest in in the March 2024 quarter at -40.82.

Quarterly (TTM)
Annual

Average

-9.56

Median

-2.70

Minimum

-27.18

Maximum

-1.01

LAVA Therapeutics N.V. (LVTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of LAVA Therapeutics N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 10.84%

Maximum Annual PE Ratio = -1.01

Minimum Annual Increase = -88.73%

Minimum Annual PE Ratio = -27.18

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1.020.98%
2023-1.01-64.61%
2022-2.8410.84%
2021-2.57-88.73%
2020-22.76-16.26%

LAVA Therapeutics N.V. (LVTX) Average PE Ratio

How has LVTX PE Ratio performed in the past?

The current PE Ratio of LAVA Therapeutics N.V. (LVTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.62

5-year avg

-6.04

10-year avg

-9.56

LAVA Therapeutics N.V. (LVTX) PE Ratio vs. Peers

How is LVTX’s PE Ratio compared to its peers?

LAVA Therapeutics N.V.’s PE Ratio is greater than CalciMedica, Inc. (-2987.83), greater than Lantern Pharma Inc. (-2.11), less than Actinium Pharmaceuticals, Inc. (-1.31), greater than Tvardi Therapeutics, Inc. (-2.81), greater than Xilio Therapeutics, Inc. (-2.53), less than PDS Biotechnology Corporation (-1.20), less than Celularity Inc. (-0.64), less than Reviva Pharmaceuticals Holdings, Inc. (-1.09), less than Tempest Therapeutics, Inc. (-0.30), less than Elutia Inc. (-1.07),

Build a custom stock screener for LAVA Therapeutics N.V. (LVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

LAVA Therapeutics N.V. (LVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like LAVA Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is LAVA Therapeutics N.V.'s PE Ratio?

How is the PE Ratio calculated for LAVA Therapeutics N.V. (LVTX)?

What is the highest PE Ratio for LAVA Therapeutics N.V. (LVTX)?

What is the 3-year average PE Ratio for LAVA Therapeutics N.V. (LVTX)?

What is the 5-year average PE Ratio for LAVA Therapeutics N.V. (LVTX)?

How does the current PE Ratio for LAVA Therapeutics N.V. (LVTX) compare to its historical average?